Xotaphen Syrup is a combination medication formulated to provide effective relief from respiratory conditions characterized by bronchospasm, excessive mucus production, and cough. It contains Levosalbutamol (1mg/5ml), a selective β2-adrenergic receptor agonist that acts as a bronchodilator, facilitating relaxation of bronchial smooth muscles and improving airflow in obstructive airway diseases such as asthma and chronic bronchitis. Ambroxol (30mg/5ml) serves as a mucolytic agent, enhancing the clearance of mucus by breaking down its structure, thereby reducing viscosity and promoting easier expectoration. Guaifenesin (50mg/5ml) functions as an expectorant, increasing respiratory tract fluid secretions to help loosen and thin mucus in the airways, further aiding in productive cough. The synergistic action of these active ingredients makes Xotaphen Syrup suitable for managing symptoms associated with acute and chronic respiratory tract infections, including bronchitis, asthma exacerbations, and other conditions involving mucus congestion and bronchospasm. It is intended for oral administration and should be used under medical supervision, with dosage adjusted according to patient age and clinical response. Caution is advised in patients with cardiovascular disorders, hypersensitivity to components, or concurrent use of other bronchodilators.